A novel prognostic six‐CpG signature in glioblastomas

AIMS: We aimed to identify a clinically useful biomarker using DNA methylation‐based information to optimize individual treatment of patients with glioblastoma (GBM). METHODS: A six‐CpG panel was identified by incorporating genome‐wide DNA methylation data and clinical information of three distinct...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CNS Neurosci Ther
Autors principals: Yin, An‐An, Lu, Nan, Etcheverry, Amandine, Aubry, Marc, Barnholtz‐Sloan, Jill, Zhang, Lu‐Hua, Mosser, Jean, Zhang, Wei, Zhang, Xiang, Liu, Yu‐He, He, Ya‐Long
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489960/
https://ncbi.nlm.nih.gov/pubmed/29350455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12786
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars